Full text

Turn on search term navigation

© 2022. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Together with a community-wide intersectoral effort to boost vaccination uptake, the COVID-naïve population in Hong Kong will decline rapidly, and so will the transmission efficiency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since its emergence in late 2019, SARS-CoV-2 has mutated at an astounding rate. In 2021, the Journal published a serological response to mRNA and inactivated vaccines in healthcare workers in Hong Kong,10 and reported cases of myocarditis and pericarditis after mRNA vaccines.11 New vaccines in novel platforms or targeting new COVID-19 variants will continue to be developed, and research directed at monitoring the efficacy and adverse effects of these vaccines will remain important to guide vaccination strategies. In the earliest months of pandemic, the Journal published radiological findings of critically ill patients diagnosed with COVID-19,13 and a case series on contrasting evidence for corticosteroid treatment for COVID-19-induced cytokine storm in children.14We anticipate publications on clinical management will remain invaluable to the medical community, perhaps with a shift in focus to greater emphasis on integrative treatment strategies,15 microbiome-based therapies, and prophylactic antiviral agents and monoclonal antibody therapies targeting vulnerable populations such as the paediatric population16 17and immunocompromised hosts. Throughout the course of the COVID-19 pandemic we have witnessed the widespread use of state-of-the-art next-generation sequencing techniques in understanding the phylogeny and evolution of SARS-CoV-2.19 20However, novelty does not necessarily require high-tech gadgets; a study by Zee et al21 illustrated how the use of rapid antigen tests can assist outbreak control in a hospital.

Details

Title
COVID-19 pandemic after Omicron
Author
Christopher KC Lai; Lam, Wilson; Tsang, KY; Cheng, Frankie WT; Martin CS Wong
First page
196
Section
EDITORIAL
Publication year
2022
Publication date
Jun 2022
Publisher
Hong Kong Academy of Medicine
ISSN
10242708
e-ISSN
22268707
Source type
Scholarly Journal
Language of publication
Chinese; English
ProQuest document ID
2714109512
Copyright
© 2022. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.